Table 2.
Conditions | R time [4.6 – 9.1 min] | CK MA[52 – 69 mm] | Heparinase R time[4.3 – 8.3 min] | Rapid TEG MA[52 – 70 mm] | FF[15 – 32 mm] |
---|---|---|---|---|---|
HYPER-coagulable | ↓ | ↑↑ | ↓ | ↑↑ | ↑↑ |
HYPO-coagulable | ↑ | ↓ | ↑ | ↓ | ↓ |
UFH infusion | ↑ | ↓/normal | normal | ||
Argatroban infusion | ↑ | ↓/normal | ↑ | ||
Conditions |
MA-ADP [45 – 69 mm] |
% inhibition [0 – 17 mm] |
|||
Inadequate platelet inhibition | normal, ↑ | < 30% | |||
Adequate platelet inhibition | ↓ (< 45 mm) | ↑↑ (> 30%) |
R = reaction time; CK MA = citrate-kaolin maximum amplitude; Rapid TEG MA = maximum amplitude under tissue factor activator; FF = functional fibrinogen; UFH = unfractionated heparin, ADP = adenosine diphosphate. MA-ADP represents clot strength in the presence of P2Y12 adenosine diphosphate-receptor blocker (e.g., clopidogrel, prasugrel).